Related Experiment Video
Updated: May 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Clinical and Pathophysiologic Correlates of Basilar Artery Measurements in Fabry Disease
Alessandra Scaravilli1, Serena Capasso1, Lorenzo Ugga1
1From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B., S.C.), University of Naples "Federico II", Naples, Italy.
Insights
Basilar artery (BA) anatomy changes in Fabry disease (FD) do not correlate with clinical or imaging findings. These BA alterations in FD appear stable over time, suggesting their role in the disease may need reevaluation.
Area of Science:
- Neurology
- Vascular Medicine
- Genetics
Background:
- Fabry disease (FD) is a rare genetic disorder affecting multiple organs.
- Alterations in basilar artery (BA) anatomy on MRA have been proposed as a feature of FD.
- The clinical and pathophysiological significance of BA remodeling in FD remains unclear.
Purpose of the Study:
- To investigate the association between basilar artery (BA) anatomical metrics and clinical, laboratory, and advanced imaging findings in Fabry disease (FD).
- To assess the longitudinal stability of BA dimensions and tortuosity in FD patients.
- To determine if baseline BA metrics can predict future clinical status in FD.
Main Methods:
- Brain MRIs from 53 FD patients were analyzed for mean BA diameter and tortuosity index.
- Correlations were tested between MRA metrics and clinical, laboratory, and posterior circulation imaging variables.
- A subgroup of 20 patients underwent 2-year follow-up to evaluate longitudinal changes and predictive ability of MRA metrics.
Main Results:
- No significant associations were found between BA diameter/tortuosity and clinical, laboratory, or advanced imaging variables.
- BA diameter and tortuosity remained stable over the 2-year follow-up period (P = .84 and P = .70, respectively).
- Baseline BA metrics did not predict the clinical status of FD patients at follow-up (P = .42 and P = .66).
Conclusions:
- Basilar artery (BA) alterations in Fabry disease (FD) lack meaningful correlation with clinical, laboratory, or imaging findings.
- The observed lack of correlation is consistent over time, indicating stability.
- The clinical relevance of basilar artery dolichoectasia in FD warrants reconsideration.
Background And Purpose:
Alterations of the basilar artery (BA) anatomy have been suggested as a possible MRA feature of Fabry disease (FD). Nonetheless, no information about their clinical or pathophysiologic correlates is available, limiting our comprehension of the real impact of vessel remodeling in FD.
Materials And Methods:
Brain MRIs of 53 subjects with FD (mean age, 40.7 [SD, 12.4] years; male/female ratio = 23:30) were collected in this single-center study. Mean BA diameter and its tortuosity index were calculated on MRA. Possible correlations between these metrics and clinical, laboratory, and advanced imaging variables of the posterior circulation were tested. In a subgroup of 20 subjects, a 2-year clinical and imaging follow-up was available, and possible longitudinal changes of these metrics and their ability to predict clinical scores were also probed.
Results:
No significant association was found between MRA metrics and any clinical, laboratory, or advanced imaging variable (P values ranging from -0.006 to 0.32). At the follow-up examination, no changes were observed with time for the mean BA diameter (P = .84) and the tortuosity index (P = .70). Finally, baseline MRA variables failed to predict the clinical status of patients with FD at follow-up (P = .42 and 0.66, respectively).
Conclusions:
Alterations of the BA in FD lack of any meaningful association with clinical, laboratory, or advanced imaging findings collected in this study. Furthermore, this lack of correlation seems constant across time, suggesting stability over time. Taken together, these results suggest that the role of BA dolichoectasia in FD should be reconsidered.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aneurysm II: Clinical Manifestations and Diagnostic Studies

